Diagnostic News and Research

RSS

Thermo Fisher to sell Athena Diagnostics and Lancaster Labs businesses for $940 million

Thermo Fisher Scientific Inc., the world leader in serving science, announced today that it has signed definitive agreements to sell its Athena Diagnostics and Lancaster Laboratories businesses for a total of $940 million in cash.

From Thermo Fisher Scientific Inc. 24 Feb 2011

Positive results from Vertex VX-770 Phase 3 STRIVE study in patients with CF

Vertex Pharmaceuticals Incorporated today announced positive results from the Phase 3 STRIVE study of VX-770, an oral medicine in development that targets the defective protein that causes cystic fibrosis.

24 Feb 2011

Opsens completes pre-clinical EasyWire device study for measurement of FFR in coronary arteries

Opsens Inc. said today that its Medical Division has reached a significant milestone, successfully completing a pre-clinical animal study on the EasyWire device, designed to measure Fractional Flow Reserve in the evaluation of coronary lesions.

24 Feb 2011

Quanterix expands its Single Molecule Array technology to measure proteins precisely

Quanterix Corporation, a single molecule diagnostics company providing technology with unprecedented sensitivity for the life science and in vitro diagnostics markets, today announced the online publication of a study that builds upon the company's Single Molecule Array technology by combining digital and analog detection in one straightforward measurement.

24 Feb 2011

FDA allows marketing of Ridascreen Norovirus 3rd Generation EIA assay in the US

The U.S. Food and Drug Administration allowed marketing of the first test for the preliminary identification of norovirus.

24 Feb 2011

InfraReDx to showcase LipiScan IVUS Coronary Imaging System at CRT 2011

InfraReDx, Inc., a medical device company providing intelligent cardiovascular diagnostic imaging technologies, today announced that its LipiScan™ IVUS Coronary Imaging System will be featured in several presentations during the annual Cardiovascular Research Technologies (CRT) 2011 meeting, being held February 27 through March 1, 2011 at the Omni Shoreham Hotel in Washington, D.C.

24 Feb 2011

'Current Concepts' article outlines ultrasound use among clinicians

Clinicians have often referred to ultrasound technology as the "stethoscope of the future," predicting that as the equipment shrinks in size, it will one day be as common at the bedside as that trusty tool around every physician's neck. According to a new report in The New England Journal of Medicine, that day has arrived.

24 Feb 2011

CST, Astellas Pharma enter commercialization partnership for cancer diagnostic, therapeutic products

Cell Signaling Technology, Inc. of Danvers, MA announced today a joint commercialization partnership with Astellas Pharma, Inc. of Tokyo, Japan focused on the delivery of personalized cancer therapeutics and diagnostics.

From Cell Signaling Technology 24 Feb 2011

New research: Spinal fluid proteins can differentiate nPTLS from Chronic Fatigue Syndrome

Patients who suffer from Neurologic Post Treatment Lyme disease and those with the Chronic Fatigue Syndrome report similar symptoms. However unique proteins discovered in spinal fluid can distinguish those two groups from one another and also from people in normal health, according to new research conducted by a team led by Steven E. Schutzer, MD, of the University of Medicine and Dentistry of New Jersey - New Jersey Medical School, and Richard D. Smith, Ph.D., of Pacific Northwest National Laboratory.

24 Feb 2011

Solos Endoscopy to launch new urology product line

Solos Endoscopy, Inc. is pleased to announce that the Company is set to introduce a new product line consisting of urology surgical and diagnostic instruments.

24 Feb 2011

FDA clears Agendia's breast cancer recurrence assay

Agendia, a world leader in molecular cancer diagnostics, today announced that the company has received its fifth U.S. Food and Drug Administration clearance for MammaPrint, its widely used breast cancer recurrence assay.

23 Feb 2011

Genetic testing should be conducted by qualified health professionals

In a letter to theFood and Drug Administration (FDA), the American Medical Association (AMA) today called for genetic testing to be conducted under the guidance of a physician, genetic counselor, or other genetics specialist. The letter was sent to the Molecular and Clinical Genetics Panel of the FDA's Medical Devices Advisory Committee regarding direct to consumer genetic tests prior to the panel’s hearings on the topic, scheduled for March 8 and 9.

23 Feb 2011

MEDSEEK chosen by Trinity Health to implement online patient experience

MEDSEEK, a provider of enterprise eHealth solutions that give patients, clinicians and administrative staff an optimal 360-degree online experience, today announced plans to deepen its relationship with long-time partner Trinity Health. It will develop, design and implement the healthcare system’s fully integrated online patient experience.

23 Feb 2011

ASGE announces 35 new honorees under Endoscopy Unit Recognition Program

The American Society for Gastrointestinal Endoscopy (ASGE) has recognized 35 endoscopy units as part of its program specifically dedicated to promoting quality in endoscopy, in all settings where it is practiced in the United States. The ASGE Endoscopy Unit Recognition Program honors endoscopy units that follow the ASGE guidelines on privileging, quality assurance, endoscopy reprocessing and CDC infection control guidelines. To date, 307 endoscopy units have been recognized by ASGE.

23 Feb 2011

T.H.E. Clinic to provide CompuMed's ECG telemedicine, CardioGramKids technology to Lennox School District

CompuMed, Inc., a telemedicine and medical informatics company, has entered into an agreement with T.H.E. Clinic to provide CompuMed's electrocardiogram (ECG) telemedicine and CardioGramKids® technology and services to the students and parents of the Lennox School District, at the Lennox Healthy Start Clinic operated by T.H.E. (To Help Everyone) Clinic, Inc.

23 Feb 2011

Researchers discover biological pathway that alters normal cells into aggressive tumors

A biological pathway that transforms normal cells into aggressive tumors has been discovered by researchers at Cleveland Clinic's Lerner Research Institute.

23 Feb 2011

Biomoda completes sample collection in pilot study of CyPath diagnostic assay for lung cancer

Cancer diagnostics company Biomoda, Inc. today announced that it has completed patient enrollment and sample collection for the pilot study to determine the clinical sensitivity and specificity of its CyPath® diagnostic assay for the early detection of lung cancer.

23 Feb 2011

Nationwide Children's Hospital joins Autism Speaks ATN to offer patient care

Nationwide Children's Hospital has been selected to join the Autism Speaks Autism Treatment Network, connecting Columbus with Cincinnati Children's Hospital Medical Center and the University of Missouri as the nation's only ATN institutions in the Midwest region.

23 Feb 2011

NanoString launches fixed-panel assay product for human molecular karyotyping

NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced the first fixed-panel assay product to be developed on its Copy Number Variation detection platform - the nCounter Human Karyotype Panel.

From NanoString Technologies 22 Feb 2011

Autism could be detected earlier and easier: Study

Scientists at Boston may have found the beginnings of a non-invasive diagnostic test that can detect abnormal brain waves that suggest increased risk for autism – a debilitating neurological disorder in babies. This test would be safe, inexpensive, and easy to perform and could make it possible for at-risk kids to get help right away rather than having to wait until months or years later, which is now the case with the behavioral tests believe experts.

22 Feb 2011

Diagnostic News and Research

Thermo Fisher to sell Athena Diagnostics and Lancaster Labs businesses for $940 million

Positive results from Vertex VX-770 Phase 3 STRIVE study in patients with CF

Opsens completes pre-clinical EasyWire device study for measurement of FFR in coronary arteries

Quanterix expands its Single Molecule Array technology to measure proteins precisely

FDA allows marketing of Ridascreen Norovirus 3rd Generation EIA assay in the US

InfraReDx to showcase LipiScan IVUS Coronary Imaging System at CRT 2011

'Current Concepts' article outlines ultrasound use among clinicians

CST, Astellas Pharma enter commercialization partnership for cancer diagnostic, therapeutic products

New research: Spinal fluid proteins can differentiate nPTLS from Chronic Fatigue Syndrome

Solos Endoscopy to launch new urology product line

FDA clears Agendia's breast cancer recurrence assay

Genetic testing should be conducted by qualified health professionals

MEDSEEK chosen by Trinity Health to implement online patient experience

ASGE announces 35 new honorees under Endoscopy Unit Recognition Program

T.H.E. Clinic to provide CompuMed's ECG telemedicine, CardioGramKids technology to Lennox School District

Researchers discover biological pathway that alters normal cells into aggressive tumors

Biomoda completes sample collection in pilot study of CyPath diagnostic assay for lung cancer

Nationwide Children's Hospital joins Autism Speaks ATN to offer patient care

NanoString launches fixed-panel assay product for human molecular karyotyping

Autism could be detected earlier and easier: Study

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News